Diversified Healthcare Trust insider trading
Every open-market purchase and sale by Diversified Healthcare Trust's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $97,800 1 trade by 1 insider
3 months later: median +48.9% (+50.4% vs S&P 500) Insider sales, 5 years $0 0 trades by 0 insiders
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Diversified Healthcare Trust’s insiders pay?
From July 9, 2010 to December 16, 2025, 4 insiders reported 5 open-market purchases and 3 sales not made under a pre-set plan in Diversified Healthcare Trust. After sales, the shares moved −6.9% against the index over 12 months (a negative figure means selling was the right call).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Portnoy Adam D. | Director | 4 | — | — | 0 | — | June 14, 2023 |
| Harrington John L. | Director | 0 | — | — | 2 | — | May 12, 2021 |
| Bilotto Christopher J. | President and CEO | 1 | — | — | 0 | — | December 16, 2025 |
| Zeytoonjian Frederick N | Director | 0 | — | — | 1 | −6.9% (1) | July 9, 2010 |
← Back to Diversified Healthcare Trust · Funds · Politicians